Affiliation:
1. Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada
2. Division of Gastroenterology, Centre Hospitalier Universitaire de Québec (CHU), Laval University, Québec, Québec, Canada
Abstract
Abstract
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder, which impacts the quality of life, work productivity and social activities of patients. Diarrhea-predominant IBS (IBS-D) is one of several subtypes, and accounts for approximately one third of all cases. Currently available treatments are typically unable to alleviate the cardinal symptoms of IBS-D, including abdominal pain and diarrhea, and a clinical unmet need remains for an effective treatment which simultaneously relieves multiple symptoms. Patients may benefit from a multipronged, individualized approach, including dietary modifications, and psychological and pharmacological therapies. The aim of this review is to provide an update on the available and upcoming treatment options for IBS-D in Canada, with reference to the recently updated Canadian IBS consensus guidelines. Initial treatment approaches include lifestyle modifications, dietary modifications, and non-prescription therapies such as peppermint oil. While some medications such as tricyclic antidepressants are also used to treat IBS-D symptoms, eluxadoline and rifaximin are the only two pharmacological therapies approved for the treatment of IBS-D in Canada. Key clinical trial data for the currently available pharmacological options are presented to provide an overview of the efficacy and safety of these agents
Publisher
Oxford University Press (OUP)
Reference54 articles.
1. Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis;Lovell;Clin Gastroenterol Hepatol,2012
2. Canadian Digestive Health Foundation Public Impact Series 3: Irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact;Fedorak;Can J Gastroenterol,2012
3. The epidemiology of irritable bowel syndrome;Canavan;Clin Epidemiol,2014
4. Bowel disorders;Lacy;Gastroenterology,2016
5. Functional gastrointestinal disorders: History, pathophysiology, clinical features, and Rome IV;Drossman;Gastroenterology,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献